• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Generic Biologics Face Uphill Battle

    Morningstar generic-pharmaceuticals analyst Brian Laegeler discusses the outlook for generic biologics in the U.S. given a strong branded-drug lobby and complex manufacturing processes.

  2. Will 'Knockout' Mice Make a Knockout Stock?

    After a strong runup from our recommendation, is it time to take money off the table in Lexicon Pharmaceuticals?

  3. Going Global to Ease Drug Trial Process

    Contract research organization Parexel is exploiting its global footprint to rapidly enroll patients in drug studies.

  4. Will a Medco/Express Scripts Merger Pass Regulatory Muster?

    Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.

  1. Jazz Pharmaceuticals, Inc. JAZZ Q4 2011 Earnings Call Transcript

    Good day ladies and gentlemen and welcome to Jazz Pharmaceuticals Full Year and Fourth Quarter 2011 Financial Results Conference Call. Following an introduction from the Company, we will open the call to questions.

  2. Allergan, Inc. AGN Q1 2011 Earnings Call Transcript

    Hello and welcome to the Allergan First Quarter 2011 Earnings Call. Following today's presentation, there will be a formal question-and-answer session. At the request of the Company, today's conference is being recorded. If you have any objections, you may disconnect at this time.

  3. Allergan, Inc. AGN Q3 2012 Earnings Call Transcript

    Hello and welcome to Allergan Third Quarter 2012 Earnings Call. Following today's presentation, there will be a formal question-and-answer session. At the request of the Company today's conference is being recorded. If anyone has any objection, you may disconnect at this time.

  4. Allergan, Inc. AGN Q4 2010 Earnings Call Transcript

    Hello, and welcome to the Allergan Fourth Quarter 2010 Earnings Call. Following today's presentation, there will be a formal question-and-answer session. (Operator Instructions). At the request of the Company, today's conference is being recorded. If anyone has any objections, you may disconnect at ...

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.